The Prostate Cancer Foundation (PCF) today announced the recipients of its 2025 Challenge Awards, providing over $12 million in funding for 12 multi-institutional, cross-disciplinary research teams ...

Scientists have identified a novel two-pronged treatment method, offering significant potential for patients battling advanced prostate cancer. Experts at The Institute of Cancer Research, London, ...

An experimental immunotherapy drug called VIR-5500 has driven prostate-specific antigen (PSA) levels down by as much as 99% in some men with metastatic castration-resistant prostate cancer, according ...

Pfizer announces phase 3 TALAPRO-3 study of talzenna plus Xtandi significantly improves rPFS in metastatic prostate cancer: New York Friday, March 20, 2026, 09:00 Hrs [IST] Pfizer ...

Thousands of men with prostate cancer are set to get a life-extending drug on the NHS within weeks – in a breakthrough that could give families precious extra years together. For the first time, ...

Thousands of men in England living with advanced prostate cancer are poised to benefit from a new life-extending drug, talazoparib, which has been approved for NHS use. The once-daily pill, with its ...

Rishi Sunak has urged men to get checked for prostate cancer as part of a new screening drive. The former prime minister has ...

Add Yahoo as a preferred source to see more of our stories on Google. The once-daily pill, with its brand name Talzenna and produced by Pfizer, offers a crucial at-home treatment option after ...

— Cutting-edge prostate cancer projects range from AI-powered diagnosis and risk prediction to targeted therapies that overcome treatment resistance — The Prostate Cancer Foundation (PCF) today ...